Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels
Open Access
- 31 October 1990
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 62 (5), 786-790
- https://doi.org/10.1038/bjc.1990.380
Abstract
The use of continuous prognostic variables is clinically impractical, and arbitrarily chosen cut-off points can result in a loss of prognostic information. Here we report findings from a study of primary breast cancer, showing how the prognostic value of the fraction of cells in the S-phase of the cell cycle (SPF), as measured by flow cytometry, can be affected by the SPF cut-off level(s) adopted. It was possible to evaluate the SPF in 566 (94%) of 603 consecutive cases where fresh frozen specimens were available in a tumour bank at our department. Clinically, all patients were without distant spread at the time of diagnosis, and the median duration of follow-up was 4 years. Using different survival end-points and .chi.2 values for each cut-off level, tow optimal cut-off points, at the 7% and 12% levels, were consistently obtained for the SPF. Furthermore, both disease-free survival and the relative risk of recurrence exhibited a non-linear relationship with SPF values; the curves implied that the prognosis was better among patients with SPF values about 2-5% than in patients with lower SPF values (parabolic shape), though the relationship with higher SPF values approached linearity. The non-linearity of the curves is incompatible with the general use of the median SPF as a prognostic cut-off value. An alternative procedure might be to use two cut-off levels, one to distinguish patients with the lowest SPF values (i.e. within the parabolic survival curve) from those with higher values (i.e. with a survival curve approaching linearity), the other to distinguish between patients with intermediate SPF values and those with high values (i.e. within the almost linear part of the survival curve). The 7% and 12% obtained here would be suitable for this purpose. We conclude that prognostic information can be gained by dividing the SPF into three prognostic categories (< 70%, 7.0-11.9% and .gtoreq. 12%), instead of using the median SPF level.This publication has 17 references indexed in Scilit:
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990
- Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithmCytometry, 1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Factors affecting relapse in node-negative breast cancer. A multivariate analysis including the labeling indexEuropean Journal of Cancer and Clinical Oncology, 1989
- Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptorsBreast Cancer Research and Treatment, 1988
- Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancerBreast Cancer Research and Treatment, 1986
- The long‐term prognostic significance of the thymidine labelling index in breast cancerInternational Journal of Cancer, 1984
- Picogram per cell determination of DNA by flow cytofluorometryAnalytical Biochemistry, 1984
- Preparation of tissues for DNA flow cytometric analysisCytometry, 1980
- Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycleRadiation and Environmental Biophysics, 1975